Blood management strategies for total knee arthroplasty

Journal of the American Academy of Orthopaedic Surgeons

Volumn 22, Issue 6, 2014, Pages 361-371

  Levine, Brett Russell ^a   Haughom, Bryan ^a   Strong, Benjamin ^b   Hellman, Michael ^a   Frank, Rachel M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOSTATIC AGENT;

BLOOD COMPONENT THERAPY; ELECTROCOAGULATION; HEMODILUTION; HEMOSTASIS; HUMAN; KNEE ARTHROPLASTY; LASER COAGULATION; METHODOLOGY; OPERATIVE BLOOD LOSS; REVIEW; TOURNIQUET;

ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD COMPONENT TRANSFUSION; BLOOD LOSS, SURGICAL; ELECTROCOAGULATION; HEMODILUTION; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; LASER COAGULATION; TOURNIQUETS;

EID: 84906556613     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/JAAOS-22-06-361     Document Type: Article

References (51)

1. Spahn DR: Anemia and patient blood management in hip and knee surgery: A systematic review of the literature. Anesthesiology 2010;113(2):482-495.
2. Barsoum WK, Klika AK, Murray TG, Higuera C, Lee HH, Krebs VE: Prospective randomized evaluation of the need for blood transfusion during primary total hip arthroplasty with use of a bipolar sealer. J Bone Joint Surg Am 2011;93(6): 513-518.
3. Seo JG, Moon YW, Park SH, Kim SM, Ko KR: The comparative efficacies of intraarticular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2013;21(8):1869-1874.
4. Sehat KR, Evans R, Newman JH: How much blood is really lost in total knee arthroplasty? Correct blood loss management should take hidden loss into account. Knee 2000;7(3):151-155.
5. Marulanda GA, Krebs VE, Bierbaum BE, et al: Hemostasis using a bipolar sealer in primary unilateral total knee arthroplasty. Am JOrthop (Belle Mead NJ) 2009;38(12): E179-E183.
6. Notarnicola A, Moretti L, Martucci A, et al: Comparative efficacy of different doses of fibrin sealant to reduce bleeding after total knee arthroplasty. Blood Coagul Fibrinolysis 2012;23(4):278-284.
7. Kirkley SA, Cowles J, Pellegrini VD, Harris CM, Boyd AD, Blumberg N: Blood transfusion and total joint replacement surgery: T helper 2 (TH2) cytokine secretion and clinical outcome. Transfus Med 1998;8(3):195-204.
8. Klein HG: How safe is blood, really? Biologicals 2010;38(1):100-104.
9. Stulberg BN, Zadzilka JD: Blood management issues using blood management strategies. J Arthroplasty 2007;22(4 suppl 1):95-98.
10. Nelson CL, Fontenot HJ, Flahiff C, Stewart J: An algorithm to optimize perioperative blood management in surgery. Clin Orthop Relat Res 1998;(357): 36-42.
11. Keating EM, Ritter MA: Transfusion options in total joint arthroplasty. J Arthroplasty 2002;17(4 suppl 1):125-128.
12. Ahmed I, Chan JK, Jenkins P, Brenkel I, Walmsley P: Estimating the transfusion risk following total knee arthroplasty. Orthopedics 2012;35(10):e1465-e1471.
13. Cuenca J, García-Erce JA, Martínez F, Cardona R, Pérez-Serrano L, Muñoz M: Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement. Int J Surg 2007;5(2):89-94.
14. Lachance K, Savoie M, Bernard M, et al: Oral ferrous sulfate does not increase preoperative hemoglobin in patients scheduled for hip or knee arthroplasty. Ann Pharmacother 2011;45(6):764-770.
15. Kourtzis N, Pafilas D, Kasimatis G: Blood saving protocol in elective total knee arthroplasty. Am J Surg 2004;187(2): 261-267.
16. Bezwada HP, Nazarian DG, Henry DH, Booth RE Jr: Preoperative use of recombinant human erythropoietin before total joint arthroplasty. J Bone Joint Surg Am 2003;85(9):1795-1800.
17. Pierson JL, Hannon TJ, Earles DR: A blood-conservation algorithm to reduce blood transfusions after total hip and knee arthroplasty. J Bone Joint Surg Am 2004; 86(7):1512-1518.
18. Deutsch A, Spaulding J, Marcus RE: Preoperative epoetin alfa vs autologous blood donation in primary total knee arthroplasty. J Arthroplasty 2006;21(5): 628-635.
19. Weber EW, Slappendel R, Hémon Y, et al: Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: The European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 2005;22(4):249-257.
20. Stowell CP, Chandler H, Jové M, Guilfoyle M, Wacholtz MC: An open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty. Orthopedics 1999;22(1 suppl):S105-S112.
21. Lee DH, Padhy D, Lee SH, Kim TK, Choi J, Han SB: Shed blood re-transfusion provides no benefit in computer-assisted primary total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2011;19(6):926-931.
22. Bezwada HR, Nazarian DG, Henry DH, Booth RE Jr, Mont MA: Blood management in total joint arthroplasty. Am J Orthop (Belle Mead NJ) 2006;35(10): 458-464.
23. Berry DJ, Bozic KJ: Current practice patterns in primary hip and knee arthroplasty among members of the American Association of Hip and Knee Surgeons. J Arthroplasty 2010;25(6 suppl): 2-4.
24. Goodnough LT, Monk TG, Despotis GJ, Merkel K: A randomized trial of acute normovolemic hemodilution compared to preoperative autologous blood donation in total knee arthroplasty. Vox Sang 1999;77 (1):11-16.
25. Olsfanger D, Fredman B, Goldstein B, Shapiro A, Jedeikin R: Acute normovolaemic haemodilution decreases postoperative allogeneic blood transfusion after total knee replacement. Br J Anaesth 1997;79(3):317-321.
26. Juelsgaard P, Møller MB, Larsen UT: Preoperative acute normovolaemic hemodilution (ANH) in combination with hypotensive epidural anaesthesia (HEA) during knee arthroplasty surgery: No effect on transfusion rate. A randomized controlled trial [ISRCTN87597684]. BMC Anesthesiol 2002;2(1):1.
27. Whitehead DJ, MacDonald SJ: TKA sans tourniquet: Let it bleed. Opposes. Orthopedics 2011;34(9):e497-e499.
28. Thorey F, Stukenborg-Colsman C, Windhagen H, Wirth CJ: The effect of tourniquet release timing on perioperative blood loss in simultaneous bilateral cemented total knee arthroplasty: A prospective randomized study. Technol Health Care 2008;16(2):85-92.
29. Hernández-Castaños DM, Ponce VV, Gil F: Release of ischaemia prior to wound closure in total knee arthroplasty: A better method? Int Orthop 2008;32(5):635-638.
30. Tai TW, Lin CJ, Jou IM, Chang CW, Lai KA, Yang CY: Tourniquet use in total knee arthroplasty: A meta-analysis. Knee Surg Sports Traumatol Arthrosc 2011;19(7): 1121-1130.
31. Rama KR, Apsingi S, Poovali S, Jetti A: Timing of tourniquet release in knee arthroplasty: Meta-analysis of randomized, controlled trials. J Bone Joint Surg Am 2007;89(4):699-705.
32. Turner NS III, Pagnano MW, Sim FH: Total knee arthroplasty after ipsilateral peripheral arterial bypass graft: Acute arterial occlusion is a risk with or without tourniquet use. J Arthroplasty 2001;16(3): 317-321.
33. Plymale MF, Capogna BM, Lovy AJ, Adler ML, Hirsh DM, Kim SJ: Unipolar vs bipolar hemostasis in total knee arthroplasty: A prospective randomized trial. J Arthroplasty 2012;27(6): 1133-1137, e1.
34. Yang ZG, Chen WP, Wu LD: Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: A meta-analysis. J Bone Joint Surg Am 2012; 94(13):1153-1159.
35. Iwai T, Tsuji S, Tomita T, Sugamoto K, Hideki Y, Hamada M: Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. Int Orthop 2013;37(3):441-445.
36. Lee SH, Cho KY, Khurana S, Kim KI: Less blood loss under concomitant administration of tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty: A prospective randomized controlled trial. Knee Surg Sports Traumatol Arthrosc 2013;21 (11):2611-2617.
37. Skovgaard C, Holm B, Troelsen A, et al: No effect of fibrin sealant on drain output or functional recovery following simultaneous bilateral total knee arthroplasty: A randomized, double-blind, placebo-controlled study. Acta Orthop 2013;84(2):153-158.
38. Kim HJ, Fraser MR, Kahn B, Lyman S, Figgie MP: The efficacy of a thrombin-based hemostatic agent in unilateral total knee arthroplasty: A randomized controlled trial. J Bone Joint Surg Am 2012;94(13): 1160-1165.
39. Palm MD, Altman JS: Topical hemostatic agents: A review. Dermatol Surg 2008;34 (4):431-445.
40. Moonen AF, Knoors NT, van Os JJ, Verburg AD, Pilot P: Retransfusion of filtered shed blood in primary total hip and knee arthroplasty: A prospective randomized clinical trial. Transfusion 2007;47(3):379-384.
41. Martin A, von Strempel A: Transfusion of autologous blood from reinfusion systems in total knee arthroplasty. Int Orthop 2006;30(6):541-544.
42. Matsuda K, Nozawa M, Katsube S, Maezawa K, Kurosawa H: Activation of fibrinolysis by reinfusion of unwashed salvaged blood after total knee arthroplasty. Transfus Apher Sci 2010;42(1):33-37.
43. Al-Zahid S, Davies AP: Closed suction drains, reinfusion drains or no drains in primary total knee replacement? Ann R Coll Surg Engl 2012;94(5):347-350.
44. So-Osman C, Nelissen R, Te Slaa R, Coene L, Brand R, Brand A: A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte-depleted red blood cells. Vox Sang 2010;98(1):56-64.
45. Hajjar LA, Vincent JL, Galas FR, et al: Transfusion requirements after cardiac surgery: The TRACS randomized controlled trial. JAMA 2010;304(14): 1559-1567.
46. Carson JL, Terrin ML, Noveck H, et al: Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011;365(26):2453-2462.
47. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies: Practice guidelines for perioperative blood transfusion and adjuvant therapies: An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006;105(1):198-208.
48. Carson JL, Duff A, Berlin JA, et al: Perioperative blood transfusion and postoperative mortality. JAMA 1998;279 (3):199-205.
49. Weiskopf RB, Viele MK, Feiner J, et al: Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998;279(3):217-221.
50. Robinson PM, Obi N, Harrison T, Jeffery J: Changing transfusion practice in total hip arthroplasty: Observational study of the reduction of blood use over 6 years. Orthopedics 2012;35(11): e1586-e1591.
51. Carson JL, Kuriyan M: What should trigger a transfusion? Transfusion 2010;50(10): 2073-2075.